| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.695 | 47.793 | 46.833 | 57.339 | 69.082 | 79.728 | 91.680 | 96.096 | 130.832 | 161.342 |
| Total Income - EUR | 41.735 | 47.804 | 46.833 | 57.339 | 69.083 | 81.796 | 91.682 | 96.096 | 130.848 | 161.372 |
| Total Expenses - EUR | 19.253 | 22.440 | 28.898 | 31.118 | 30.492 | 35.542 | 44.451 | 61.354 | 64.863 | 39.324 |
| Gross Profit/Loss - EUR | 22.482 | 25.364 | 17.935 | 26.221 | 38.591 | 46.255 | 47.231 | 34.743 | 65.985 | 122.048 |
| Net Profit/Loss - EUR | 21.230 | 24.886 | 17.467 | 25.651 | 37.855 | 45.515 | 46.314 | 33.782 | 64.677 | 117.207 |
| Employees | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Medifam Dr. Tanasa Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 198 | 196 | 192 | 189 | 185 | 182 | 31 | 31 | 518 | 263 |
| Current Assets | 15.735 | 2.132 | 522 | 1.741 | 7.898 | 4.161 | 53.302 | 40.992 | 81.218 | 124.278 |
| Inventories | 115 | 0 | 1 | 7 | 11 | 0 | 0 | 0 | 14 | 1.689 |
| Receivables | 15.094 | 28 | 222 | 536 | 7.260 | 1.370 | 50.983 | 38.795 | 64.002 | 63.496 |
| Cash | 526 | 2.104 | 299 | 1.198 | 627 | 2.791 | 2.319 | 2.196 | 17.202 | 59.094 |
| Shareholders Funds | 13.626 | 653 | -7.175 | -8.469 | 5.654 | 1.135 | 46.362 | 33.830 | 64.725 | 117.360 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.307 | 1.674 | 7.890 | 10.399 | 2.430 | 3.208 | 6.971 | 7.193 | 17.011 | 7.181 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medifam Dr. Tanasa Srl